Home

DSC Advisors, L.P.

CIK 1299434 · last filed 2017-09-15

DSC Advisors, L.P. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing shows the insider bought $5.3M of KMPH on Sep 15, 2017. Across all open-market trades the lifetime net is +$5.3M, making them a net buyer over the disclosed history. The firm reports its address in Chicago, IL. 8 SEC filings were submitted jointly with ANDREW G BLUHM.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$5.33M

Filer Profile

Reported Address
900 NORTH MICHIGAN AVENUE
SUITE 1600
CHICAGO, IL 60611
Phone
(312) 915-2485
State of Incorporation
DE
Related Filers
ANDREW G BLUHM — 8 joint filings, latest 2018-10-09
DSC Advisors, L.L.C. — 6 joint filings, latest 2018-10-09
DSC Managers, L.L.C. — 6 joint filings, latest 2018-10-09
Delaware Street Capital Master Fund, L.P. — 6 joint filings, latest 2018-10-09
GCM Grosvenor Inc. — same reported address
Labor Impact Fund, L.P. — same reported address
Pacific Trail Holdings, LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZEVRA THERAPEUTICS, INC. (KMPH) Delisted 10%+ Owner 103,298 $5.81 $600.2K $5.33M 1 2017-09-15

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-09-15 ZEVRA THERAPEUTICS, INC. (KMPH) Delisted Buy (P) +1,629,440 $5.33M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.